Keeping Institutional Fee Discussions Inside the Approval Process
Guide institutional sales teams through early fee questions without inventing commercial terms.
An allocator asks about fees before you have any of the information you need to answer responsibly. Asset size, vehicle, service scope, consultant involvement, and your own firm's approval process all shape what a real number looks like. Give a rough figure just to keep the conversation moving, and you may have created a commitment your commercial team never agreed to.
Why this conversation goes wrong
Sales reps feel pressure to answer every question directly, especially early in a relationship when hesitation reads as weakness. A staff member at a public plan or a corporate pension asks a plain question, can you beat our current fee, and it feels rude or evasive to say you need more information first. So reps guess. They anchor on a number that sounds competitive, based on a deal they closed last year or a rate they remember from a pitch book. That number travels. It ends up in the allocator's notes, gets repeated to a consultant, and becomes the baseline your firm is negotiating against months later, even though nobody with pricing authority ever approved it. The rep who gave the number rarely intended to bind the firm. They intended to sound confident. But allocators do not distinguish between a confident guess and a firm commitment, and neither does the consultant who later builds a shortlist comparison around it. The deal is not lost because the number was wrong. It is lost, or made harder, because the number was said too early, without the assumptions that would have made it defensible.
How to prepare
Before you take a fee question, know what determines your answer. Learn the mandate size ranges your firm prices differently, which vehicle options exist for this strategy, and what services are bundled in at each tier. Know who owns commercial terms internally, whether that is a product specialist, a pricing committee, or a senior relationship manager, and how quickly that person can turn around an approved number. Write these details down somewhere you can reference quickly, a one page reference sheet works fine, so you are not trying to recall pricing tiers from memory while an allocator is watching your face for hesitation. Ask your desk what format consultants typically want a fee proposal in, since many require a specific worksheet or scaled schedule rather than a single flat number. If you sell into public plans, understand the procurement rules that govern how your firm can even communicate pricing outside a formal RFP process. None of this preparation lets you answer a premature question with a number. It lets you answer it with the right next question, and it tells you exactly what information you are missing before you can move the conversation forward. The Asset Management practice conversations library is a good place to rehearse this kind of exchange before it happens with a real allocator.
What to say
Treat the first fee question as discovery, not negotiation. Your job is to find out what the allocator is comparing, which assumptions apply to their mandate, and whether they want a screening range or a formal proposal tied to their process.
At a first meeting, a staff member from a public plan asks, "Can you come in below what we're currently paying."
You respond, "Cost is clearly part of your review, and I want to give you something you can actually use. To put together a number our commercial team can stand behind, can you tell me the expected asset size, the vehicle you're considering, and whether your consultant has a fee template you need this in."
The staff member says the mandate size is still being finalized and there is no consultant involved yet.
You continue, "Then I shouldn't give you a figure today, because it would be a guess dressed up as an answer. What I can do is write down the assumptions that are still open, so nothing gets lost, and bring in the person on our side who owns commercial terms as soon as your sizing firms up."
If the allocator volunteers a competing firm's fee, write down exactly what they tell you about its scope, but do not treat it as a comparable number and do not react to it as if you can beat it on the spot. A real comparison needs the same asset range, the same vehicle, the same services, and the same approval path on both sides. Most competing numbers you hear secondhand are missing at least one of those.
Mistakes to avoid
The most common mistake is naming a number to preserve momentum. It feels productive in the room and creates a problem for everyone after the room empties. A close second is treating the allocator's stated competing fee as gospel and immediately promising to undercut it, which commits your firm before anyone with authority has reviewed the comparison. A subtler mistake is treating a screening range you were authorized to share as if it were a final quote, then having to walk it back later when the real number differs. Say clearly that any range is preliminary and subject to review once the mandate details are confirmed. Another mistake is going silent instead of engaging, where a rep deflects the question entirely and says pricing will come later without explaining why or what happens next. Allocators read that as evasive, not disciplined. The fix is to stay warm and specific. Explain what you need, ask for it directly, and tell them what happens once you have it. Reps also sometimes forget to document the conversation the same day. If you do not write down the assumptions that were open and the questions that were unanswered, the next call starts from scratch, and the allocator remembers a version of the conversation that may not match what you actually said. This same discipline matters in adjacent conversations, like the one covered in Preparing for an Institutional Finalist Meeting, where commercial questions often resurface under more pressure and less time.
How to practice and score it
This is a conversation worth rehearsing before it happens with a real allocator, because the instinct to fill silence with a number is strong and hard to unlearn in the moment. A manager running practice sessions should put the rep in exactly this scenario, a plan or endowment staff member asking for a number the rep is not authorized to give, and score three things. First, did the rep decline to name a figure without becoming defensive or vague. Second, did the rep ask for the specific inputs, asset size, vehicle, service scope, consultant format, that actually determine a real quote. Third, did the rep name the internal owner of commercial terms and give a concrete next step, rather than a vague promise to follow up. A rep who nails the refusal but never gets to the useful discovery questions has only done half the job. Practicing this scenario repeatedly with an AI counterpart, the kind DealSpeak is built around, lets a rep make the mistake of guessing a number in private, see how it plays out, and correct it before it costs a real mandate. The same approach works for other pressure points institutional sales teams hit early, including the spending and liquidity concerns raised in Talking With a Foundation About Spending Pressure and Illiquidity.
A fee question this early is not a test of your firm's price. It is a test of your process, and allocators notice which firms have one. Handle it by asking for the inputs you actually need, naming who owns the answer, and following up when your process, not your instinct, has something real to say.
Practice these next
A careful way for institutional sales teams to handle capacity questions using approved evidence.
Guide institutional sales teams through a careful conversation about a concentrated legacy holding.
Guide an insurer duration discussion toward documented assumptions and the right diligence owners.
Give institutional sales teams a disciplined way to describe process, risk, and evidence.
Teach institutional sales teams to map stakeholders without assuming influence.
Help institutional sales teams support a search led by a consultant while respecting the allocator's process.